Gastric acid hypersecretion in refractory gastroesophageal reflux disease

Gastroenterology

Volumn 98, Issue 3, 1990, Pages 654-661

  Collen, Martin J ^a   Lewis, James H ^a   Benjamin, Stanley B ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RANITIDINE;

ARTICLE; GASTROESOPHAGEAL REFLUX; HUMAN; HUMAN EXPERIMENT; PRIORITY JOURNAL; STOMACH ACID SECRETION;

ADOLESCENT; ADULT; AGED; CHRONIC DISEASE; COMPARATIVE STUDY; DOSE-RESPONSE RELATIONSHIP, DRUG; ESOPHAGITIS; ESOPHAGUS; GASTRIC ACID; GASTRIC ACIDITY DETERMINATION; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; HYDROGEN-ION CONCENTRATION; MANOMETRY; MIDDLE AGE; PROSPECTIVE STUDIES; RANITIDINE; TIME FACTORS;

EID: 0025037553     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/0016-5085(90)90285-9     Document Type: Article

References (58)

1. Symptomatic gastroesophageal reflux: incidence and precipitating factors
2. Gastro-esophageal reflux in the irritable bowel syndrome
3. Why do apparently healthy people use antacid tablets?
4. Oral cimetidine in reflux esophagitis: a double blind controlled trial
5. Cimetidine in the treatment of symptomatic gastroesophageal reflux. A double blind controlled trial
6. Oral cimetidine in reflux esophagitis: a double-blind controlled trial
7. Controlled trial of cimetidine in reflux esophagitis
8. Medical therapy of reflux esophagitis
9. Gastroesophageal reflux disease: acute and maintenance treatments with cimetidine
10. Treatment of reflux esophagitis with ranitidine
11. Ranitidine in the treatment of symptomatic gastroesophageal reflux disease
12. Healing and relapse of reflux esophagitis during treatment with ranitidine
13. Doubleblind crossover study of ranitidine and placebo in gastro-oesophageal reflux disease
14. Ranitidine therapy for gastroesophageal reflux disease: results of a large doubleblind trial
15. Once-daily administration of famotidine for reflux esophagitis
16. Effects of long term maintenance cimetidine therapy on gastroesophageal reflux disease (abstr)
17. Ranitidine versus placebo in long-term treatment of gastroesophageal reflux (GERD) (abstr)
18. Gastroesophageal reflux: pathogenesis, diagnosis, and therapy
19. Gastroesophageal reflux in the Zollinger-Ellison syndrome
20. Composition of the refluxed material determines the degree of reflux esophagitis in the dog
21. Role of acid and pepsin in acute experimental esophagitis
22. Role of the components of the gastroduodenal contents in experimental acid esophagitis
23. Basal acid output in patients with gastroesophageal reflux disease (abstr)
24. Refractory duodenal ulcers (nonhealing duodenal ulcers with standard doses of antisecretory medication)
25. Omeprazole is superior to ranitidine in the treatment of reflux esophagitis (abstr)
26. Double-blind multicenter comparison of omeprazole and ranitidine in the treatment of reflux esophagitis
27. Omeprazole (40 mg) is superior to ranitidine in the short-term treatment of ulcerative reflux esophagitis
28. Omeprazole versus ranitidine in erosive esophagitis
29. Healing and relapse of severe peptic esophagitis after treatment with omeprazole
30. Histologic evaluation of chronic gastroesophageal reflux. An evaluation of biopsy methods and diagnostic criteria
31. Barrett's esophagus: a prevalent, occult complication of gastroesophageal reflux disease
32. Esophageal manometry in 95 healthy adult volunteers: variability of pressures with age and frequency of “abnormal” contractions
33. Esophageal testing of patients with noncardiac chest pain or dysphagia. Results of three years' experience with 1161 patients
34. Technical aspects of intraluminal pH-metry in man: current status and recommendations
35. Reliability of symptoms in assessing control of gastric acid secretion in patients with Zollinger-Ellison syndrome
36. Idiopathic gastric acid hypersecretion (abstr)
37. Zollinger-Ellison syndrome. Current concepts in diagnosis and management
38. Comparison of ranitidine and cimetidine in the treatment of gastric hypersecretion
39. Mechanisms of gastroesophageal reflux in patients with reflux esophagitis
40. Factors that influence induction of gastroesophageal reflux in normal human subjects
41. 2 antagonists in the treatment of reflux oesophagiris: can physiologic studies predict the response?
42. Esophageal epithelial response to gastroesophageal reflux: a quantitative study
43. Daytime gastro-oesophageal reflux is important in oesophagitis
44. Oesophageal function after oral ranitidine: an acute double blind study in normal subjects
45. Abnormal esophageal pressures in reflux esophagitis: cause or effect?
46. Does healing of esophagitis improve esophageal motor function?
47. Gastro-oesophageal function in normal subjects after oral administration of ranitidine
48. 24-hour esophageal pH monitoring before and after medical therapy for reflux esophagitis
49. Long-term management of peptic ulcer disease and gastroesophageal reflux disease
50. 2 antagonist therapy for gastroesophageal reflux disease?
51. Experimental esophagitis in a rabbit model
52. Mechanism of action of omeprazole
53. Peptic ulcer
54. The treatment of gastric ulcer with antisecretory drugs. Relationship of pharmacological effect to healing rates
55. Medical therapy for chronic reflux esophagitis: long-term follow-up
56. 2-receptor-antagonists?